Kailera Therapeutics, Inc.

NASDAQ:KLRA

Biotechnology

Healthcare
$11.79 +2.66%

+$0.51 today

Market cap
$1.53B
Beta
0.00
52W Low $18.50High $28.23

Volume 0.42M

Average 0.80M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$158.34M

FY 2025 · Annual

Net Income

-$148.96M

FY 2025 · Annual

KLRA Earnings Waterfall · TTM

NASDAQ:KLRA · Revenue to Net Income

No earnings data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 4, 2026
8-KCurrent reportNov 4, 2026
3Initial statement of beneficial ownershipSep 9, 2026
4Statement of changes in beneficial ownershipSep 9, 2026
SC 13GSC 13G filingAug 14, 2026

How much revenue does KLRA generate?

Kailera Therapeutics, Inc. (KLRA) reported $0.00 of revenue in fiscal 2025.

Is KLRA profitable?

Kailera Therapeutics, Inc. (KLRA) reported -$148.96M of net income.